PFE · News · 20260920N
Drug Pricing Policy
PFIZER INC · 2026-09-20 · Importance 37 · Surprise 42 · In source text
Pfizer agreed to share a portion of increased overseas drug revenue with the U.S. Department of Health and Human Services (HHS) under a “most favored nation” contract. The agreement is intended to ensure that higher prices charged abroad benefit U.S. patients and taxpayers through lower domestic costs. Public Citizen obtained the agreement through a Freedom of Information Act lawsuit, but the revenue-sharing rate and medicines covered remain redacted. The financial impact is not quantifiable from the reported disclosures.
Key facts
- Pfizer has agreed to share a portion of its increased overseas drug revenue with the US Department of Health and Human Services (HHS), stemming from a "most favored nation" contract. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | negative | committed | — | Pfizer has agreed to share a portion of its increased overseas drug revenue with the US Department of Health and Human Services (HHS),… |